Global Biotech Ingredients Market is segmented By Type (Innovative Biotech APIs, Generic biotech APIs/ Biosimilar), By Product (Monoclonal Antibodies, Vaccines, Cytokines, Fusion Proteins, Therapeutic Enzymes, Hormones and Growth Factors, Blood Factors, Others), By Expression System (Microbial, Mammalian, Plant, Yeast, Insect, Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2024-2031.
Biotech Ingredients Market Size
The Global Biotech Ingredients Market reached USD 56.6 billion in 2022 and is projected to witness lucrative growth by reaching up to USD 86.0 billion by 2031. The global biotech ingredients market is expected to exhibit a CAGR of 5.5% during the forecast period (2024-2031). The global biotech ingredients market is expected to gorw significantly as a result of the increased adoption of biotechnology-driven goods in a variety of industries.
These ingredients are used in industries such as pharmaceuticals, cosmetics, food and drinks, and manufacturing. They are obtained from live organisms or synthesized utilizing biotechnological technologies. Rising demand for natural and clean-label products, and the rise of biopharmaceuticals are all significant contemporary industry trends.
The global biotech ingredients market growth is driven by factors such as increasing demand for bio-based products, growing focus on personalized medicine, increased focus on sustainable and eco-friendly solutions, advancements in bioprocessing techniques, and increasing demand for biotech flavours and fragrance ingredients.
Biotech Ingredients Market Summary
|
Metrics |
Details |
|
CAGR |
5.5% |
|
Size Available for Years |
2022-2031 |
|
Forecast Period |
2024-2031 |
|
Data Availability |
Value (US$) |
|
Segments Covered |
Type, Product, Expression System, and Region |
|
Regions Covered |
North America, Europe, Asia-Pacific, South America, and Middle East & Africa |
|
Fastest Growing Region |
Asia-Pacific |
|
Largest Region |
North America |
|
Report Insights Covered |
Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and Acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, Porter’s Analysis, Pricing Analysis, Regulatory Analysis, Supply-Chain Analysis, and Orthopedic Surgery key Insights. |
To know more insights Download Sample
Biotech Ingredients Market Dynamics
The Increasing Demand for Biotech Flavors and Fragrance Ingredients will Drive the Global Biotech Ingredients Market Growth
Biotech flavors and scent compounds are in high demand in the food and beverage industries. Customers want natural, authentic flavors, and biotech ingredients offer a feasible solution. Food and beverage businesses can improve the taste, scent, and overall sensory experience of their products by using biotech flavors and fragrance elements. The growing demand for biotech ingredients is likely to boost market expansion in the food and beverage sectors.
For example, biotech flavors and scent compounds are in high demand in the food and beverage industries. Customers want natural, authentic flavors, and biotech ingredients offer a feasible solution. For instance, in June 2022, a Danish biotech company Novozymes, launched an eco-friendly umami flavor made using engineered enzymes. Thus, the growing demand for biotech ingredients is likely to boost market expansion in the food and beverage sectors over the forecast year.
The Growing Technological Advancements will Drive the Global Biotech Ingredients Market Growth
Biotechnology advancements such as genetic engineering, synthetic biology, and bioprocessing have considerably broadened the scope of biotech substances. The discovery of innovative enzymes for industrial applications, for example, has increased the efficiency and productivity of many processes, fueling market expansion.
For instance, in March 2023, Seamless Therapeutics entered the market with €11.8 million in seed funding to build a gene-editing platform. Their primary goal is to develop "designer recombinases," which have the ability to modify large parts of genes. Recombinases are enzymes that can excise, invert, or insert DNA sequences, albeit they are usually limited to certain target sequences.
However, Seamless intends to continuously evolve these recombinases in order to create recombinases that act at the necessary regions found within human genes. Therefore, this upcoming development in technologies in the biotech field is expected to fuel the global biotech ingredients market over the forecast period.
The Limited Availability of Raw Materials 0wing to the Requirement of Ambient Conditions will Hamper the Growth of The Global Biotech ingredients Market
Over the last two decades, numerous industries have experienced tremendous expansion due to the biotechnological processes that have considerably accelerated the growth of research sectors. However, compared to other scientific disciplines, biotechnology techniques frequently include higher risks. For instance, handling the microorganisms necessary to produce biotech components might be difficult because of the inherent risks that come with their small size.
Moreover, the cost-effectiveness of raw materials and the maintenance of optimal conditions necessary for biotech ingredient production can become impractical. This can have adverse effects on both the quantity and quality of the end-products. Additionally, stringent government regulations have resulted in numerous projects being put on hold, thereby impacting the growth of the market. Thus, the limitations associated with biotechnological processes directly impede the recent growth of the biotech ingredient market.
Biotech Ingredients Market Segment Analysis
The global biotech ingredients market is segmented based on type, product, expression system, end user, and region.
The Monoclonal Antibodies Segment is Expected to Hold a Dominant Position in the Global Biotech ingredients Market Over the Forecast Period
The monoclonal antibody segment is projected to dominate the global biotech ingredients market accounting market share of about 28.9%, owing to the high specificity, low toxicity, and the ability to target specific disease marker, also the increasing prevalence of chronic diseases and the need for personalized treatment options will elevate the market growth.
Monoclonal antibodies (mAbs) are synthetically produced proteins that target specific cells or proteins and mimic the immune system's capacity to combat invaders. Due to their therapeutic uses in treating a variety of diseases, including cancer, autoimmune disorders, and infectious diseases, these biotech components have experienced tremendous growth in the pharmaceutical sector.
For example, a monoclonal antibody called trastuzumab, also known as Herceptin, is used to treat breast cancer that is HER2-positive. It targets the HER2 protein particularly, which is overexpressed in some types of breast cancer. Trastuzumab has demonstrated significant clinical efficacy, leading to improved survival rates and better treatment outcomes for patients.
Recently, in May 2002, Roche Pharma launched PHESGO, a breast cancer antibody cocktail medication in India. It is a combination of two monoclonal antibodies (Perjeta and Herceptin), and is 20% less expensive and easier to administer than conventional therapy. PHESGO is the first fixed-dose combination of its kind, and it is approved for the treatment of both early and late-stage HER2-positive breast cancer.
Source: DataM Intelligence Analysis (2023)
Biotech Ingredients Market Geographical Share
North America Holds a Dominant Position in the Global Biotech ingredients Market.
North America is estimated to hold around 37.8% of the total market share throughout the forecast period. Owing to the growing adoption of biotech ingredients, advanced research and development infrastructure, and strong biotech industry presence are some of the key factors expected to drive the global biotech ingredients market in the North America region over the forecast period.
The presence of major market players has led to growth in innovations, partnerships, and investments. For instance, in March 2023, Geno, a pioneer in sustainable materials, welcomed L'Oréal, a well-known player in the beauty business, as the third and final founding partner in its initiative. The collaboration's purpose is to discover, produce, and sell biotechnology-based alternatives for important elements found in common cosmetics, personal care products, and cleaning products.
Source: DataM Intelligence Analysis (2023)
Biotech Ingredients Market Companies
The major global players in the market include Mylan, Inc., Pfizer, Inc., Novartis AG, Sigma-Aldrich (Merck KGaA), Bristol-Myers Squibb Company, Sanofi, Teva, AstraZeneca, BD, and AbbVie Inc., among others.
COVID-19 Impact on Biotech Ingredients Market
The COVID-19 pandemic had a huge impact on the global biotech ingredients market. The rising demand for biopharmaceuticals such as vaccines and monoclonal antibodies raised the demand for biotech components used in the formulation. However, supply chain problems impacted ingredient availability. Governments and organizations concentrated on increasing vaccine manufacturing capacity, which increased demand.
Regulatory flexibility and quick approvals facilitated the timely availability of biotech substances. The pandemic sparked research and development initiatives, emphasizing the significance of continual innovation and investment in biotech elements to address new health concerns. The long-term impacts of COVID-19 on the global biotech ingredients market are still being determined.
Russia Ukraine Conflict Analysis
The Russia-Ukraine conflict has the potential to disrupt global biotech ingredient supply chains, particularly in affected countries. This might cause biotech ingredient delays or shortages around the world. Geopolitical uncertainty may have an impact on investment decisions and company operations in the biotech industry, potentially changing the global supply chain. Regulatory measures relating to the war may have an impact on trade and raise compliance costs.
Moreover, market confidence and investor sentiment may be harmed, thereby hurting funding and investment in the biotech sector. Regional biotech ingredient markets in Russia and Ukraine may encounter problems in terms of business continuity and access to international markets. Continuous monitoring and flexibility are critical for stakeholders navigating the conflict's influence on the global biotech ingredients market.
Key Developments
- In May 2023, Willow Biosciences Inc., a well-known biotech firm striving to transform industrial manufacturing of pure and sustainable functional components, signed a Master Services Agreement with an innovative biotech firm specializing in age-related disorders. It will create precise fermentation procedures for a specific class of compounds being produced as nutritional supplements for health and wellbeing, as well as active pharmaceutical ingredients (APIs) in this collaboration.
- In April 2023, Solvay is collaborating with Gingko Bioworks, a cell programming platform, to create sustainable biopolymers for use in food, agriculture, and personal care. Solvay will also purchase a Gingko facility in Cambridge, Massachusetts, as part of the arrangement, to boost its research and innovation capabilities.
- In February 2023, Grntvedt Biotech introduced CETO3, a cetoleic acid, and omega-3 component. Cetoleic acid, often known as "omega 11," has been examined for its ability to convert alpha-lipoic acid (ALA), a plant-based omega 3 fatty acids, into eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) in liver cells. The substance derived from Norwegian herring is finding use in the fields of heart and skin health.
Why Purchase the Report?
- To visualize the global biotech ingredients market segmentation based on the coating, end user and region, as well as understand key commercial assets and players.
- Identify commercial opportunities by analyzing trends and co-development.
- Excel data sheet with numerous data points of global biotech ingredients market-level with all segments.
- PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
- Product mapping available as Excel consisting of key products of all the major players.
The global biotech ingredients market report would provide approximately 49 tables, 53 figures, and 195 Pages.
Target Audience 2024
- Manufacturers/ Buyers
- Industry Investors/Investment Bankers
- Research Professionals
- Emerging Companies
